Effects of levetiracetam on the production of nitric oxide: An in vivo study [2]

Journal of Neurology

Volumn 252, Issue 6, 2005, Pages 727-730

  Dagonnier, Marie ^a   Laute, Marie Aline ^a   Pandolfo, Massimo ^a   Manto, Mario ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ETIRACETAM; N METHYL DEXTRO ASPARTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; CEREBELLUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HISTOLOGY; IN VIVO STUDY; LETTER; MALE; MICRODIALYSIS; NEUROPHARMACOLOGY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICRODIALYSIS; N-METHYLASPARTATE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PIRACETAM; QUINOXALINES; RATS; RATS, WISTAR; TIME FACTORS;

EID: 20844452569     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0726-y     Document Type: Letter

References (14)

1. Audinat E, Gahwiler BH, Knopfel T (1992) Excitatory synaptic potentials in neurons of the deep nuclei in olivo-cerebellar slice cultures. Neuroscience 49:903-911
2. Cardile V, Pavone A, Gulino R, Renis M, Scifo C, Perciavalle V (2003) Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with levetiracetam. Brain Res 976:227-233
3. Estevez AG, Spear N, Manuel SM, Radi L, Barbeito L, Beckman JS (1998) Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. In: Mize R, Fredlander M (eds) Progress in Brain Res, vol 118, Elsevier, Amsterdam, pp 269-280
4. Garthwaite J, Brodbelt AR (1989) Glutamate as the principal mossy fibre transmitter in rat cerebellum: pharmacological evidence. Eur J Neurosci 2:177-180
5. Hernandez-Viadel M, Montoliu C, Monfort P, Canales JJ, Erceg S, Rowan M, Ceccatelli S, Felipo V (2003) Chronic exposure to 2,5-hexanedione impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in rat brain in vivo. Neurochem Int 42:525-533
6. Kendrick KM, Guevara-Guzman R, de la Riva C, Christensen J, Ostergaard K, Emson PC (1996) NMDA and kainite-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur J Neurosci 8:2619-2634
7. Klitgaard H, Pitkanen A (2003) Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam. Epileptic Disord 5:S9-S16
8. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861-9866
9. Micheva KD, Holz RW, Smith SJ (2001) Regulation of presynaptic phosphatidylinositol 4,5-biphosphate by neuronal activity. J Cell Biol 23:355-368
10. Paxinos G, Watson C(1986) The rat brain in stereotactic coordinates. Academic Press, New York
11. Sequeira SM, Malva JO, Carvalho AP, Carvahlo CM (2001) Presynaptic NMDA receptor activation inhibits neurotransmitter release through nitric oxide formation in rat hippocampal nerve terminals. Brain Res Mol Brain Res 89:111-118
12. ++ neurotoxicity. Neuroscience 100:651-661
13. Wall MJ (2003) Endogenous nitric oxide modulates GABAergic transmission to granule cells in adult rat cerebellum. Eur J Neurosci 18:869-878
14. Yamada K, Nabeshima T (1997) Two pathways of nitric oxide production through glutamate receptors in the rat cerebellum in vivo. Neurosci Res 28:93-102